Point of Law has this report (linking in turn to others) describing some of the action at yesterday’s hearing on Capitol Hill about federal preemption of claims against drug and device manufacturers.
Coverage of Yesterday’s Preemption Hearing
The definitive source for intelligent commentary on the law that matters for drug and device product liability cases